As far as dockets for comment on US dietary supplement regulations go, the Food and Drug Administration’s on whether the amino acid N-acetyl-L-cysteine is safe for use as a dietary ingredient wasn’t a big attention grabber, generating a low volume of responses.
For three pharma firms, on the other hand, the docket was a riveting invitation to be heard
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?